CbdMD Analyst Ratings
CbdMD Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2023 | 210.24% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 06/18/2021 | 236.09% | Cantor Fitzgerald | $4.1 → $3.25 | Reinstates | → Neutral |
| 02/03/2021 | 323.99% | Cantor Fitzgerald | $4.3 → $4.1 | Reiterates | → Neutral |
| 01/29/2021 | 344.67% | Cantor Fitzgerald | $3.6 → $4.3 | Maintains | Neutral |
| 09/09/2020 | 313.65% | Benchmark | $3 → $4 | Maintains | Speculative Buy |
| 08/13/2020 | 272.29% | Cantor Fitzgerald | $1.8 → $3.6 | Maintains | Neutral |
| 05/18/2020 | 86.14% | Cantor Fitzgerald | $1.2 → $1.8 | Maintains | Neutral |
| 12/19/2019 | 623.89% | Benchmark | $9 → $7 | Maintains | Speculative Buy |
| 11/08/2019 | 251.6% | Cantor Fitzgerald | → $3.4 | Initiates Coverage On | → Neutral |
| 09/10/2019 | 830.71% | Benchmark | → $9 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/05/2023 | 210.24% | Maxim集團 | →$3 | 開始承保 | →購買 |
| 06/18/2021 | 236.09% | 康託·菲茨傑拉德 | $4.1→$3.25 | 恢復 | →中性 |
| 02/03/2021 | 323.99% | 康託·菲茨傑拉德 | $4.3→$4.1 | 重申 | →中性 |
| 2021/01/29 | 344.67% | 康託·菲茨傑拉德 | $3.6→$4.3 | 維護 | 中性 |
| 09/09/2020 | 313.65% | 基準 | $3→$4 | 維護 | 投機性購買 |
| 2020年08月13日 | 272.29% | 康託·菲茨傑拉德 | $1.8→$3.6 | 維護 | 中性 |
| 05/18/2020 | 86.14% | 康託·菲茨傑拉德 | $1.2→$1.8 | 維護 | 中性 |
| 2019年12月19日 | 623.89% | 基準 | $9→$7 | 維護 | 投機性購買 |
| 2019年8月11日 | 251.6% | 康託·菲茨傑拉德 | →$3.4 | 開始承保 | →中性 |
| 2019年09月10日 | 830.71% | 基準 | →$9 | 開始承保 | →投機性買入 |
What is the target price for cbdMD (YCBD)?
CbdMD(YCBD)的目標價是多少？
The latest price target for cbdMD (AMEX: YCBD) was reported by Maxim Group on October 5, 2023. The analyst firm set a price target for $3.00 expecting YCBD to rise to within 12 months (a possible 210.24% upside). 1 analyst firms have reported ratings in the last year.
Maxim Group於2023年10月5日報道了cbdMD(美國證券交易所代碼：YCBD)的最新目標價。這家分析公司將目標價定為3美元，預計YCBD將在12個月內上漲至(可能上漲210.24%)。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for cbdMD (YCBD)?
CbdMD(YCBD)的最新分析師評級是多少？
The latest analyst rating for cbdMD (AMEX: YCBD) was provided by Maxim Group, and cbdMD initiated their buy rating.
Maxim Group提供了對cbdMD(美國證券交易所代碼：YCBD)的最新分析師評級，cbdMD啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for cbdMD (YCBD)?
CbdMD(YCBD)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of cbdMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for cbdMD was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與cbdMD的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。CbdMD的上一次評級是在2023年10月5日提交的，因此您應該預計下一次評級將在2024年10月5日左右提供。
Is the Analyst Rating cbdMD (YCBD) correct?
分析師對cbdMD(YCBD)的評級正確嗎？
While ratings are subjective and will change, the latest cbdMD (YCBD) rating was a initiated with a price target of $0.00 to $3.00. The current price cbdMD (YCBD) is trading at is $0.97, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的cbdMD(YCBD)評級是以0.00美元至3.00美元的目標價啟動的。目前cbdMD(YCBD)的交易價格為0.97美元，在分析師的預測區間內。